# Posterior Capsule Opafication of Different Hydrophobic Acrylic Intraocular Lenses: Vivinex iSert P261 vs.Clareon IOL

> **NCT04369482** · NA · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 100 (actual)

## Conditions studied

- Age Related Cataracts

## Interventions

- **DEVICE:** Alcon Clareon
- **DEVICE:** Hoya Vivinex

## Key facts

- **NCT ID:** NCT04369482
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-02-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04369482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04369482, "Posterior Capsule Opafication of Different Hydrophobic Acrylic Intraocular Lenses: Vivinex iSert P261 vs.Clareon IOL". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04369482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*